PHOSPHORUS AS MONO-DI POTASSIUM PHOSPHITE - arama sonuçları

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amgrow phospot 600 systemic fungicide

amgrow pty ltd - phosphorous (phosphonic) acid present as mono & di potas - liquid - phosphorous (phosphonic) acid present as mono & di potas mineral-phosphorus acid active 600.0 g/l - fungicide

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amgrow phospot 400 ph7.2 systemic fungicide

amgrow pty ltd - phosphorous (phosphonic) acid present as mono & di potas - liquid - phosphorous (phosphonic) acid present as mono & di potas mineral-phosphorus acid active 400.0 g/l - fungicide

Kanada - İngilizce - Health Canada

potassium phosphates injection, usp solution

fresenius kabi canada ltd - potassium phosphate monobasic; potassium phosphate dibasic - solution - 224mg; 236mg - potassium phosphate monobasic 224mg; potassium phosphate dibasic 236mg - replacement preparations

ABD - İngilizce - NLM (National Library of Medicine)

potassium phosphates- potassium phosphate, monobasic potassium phosphate, dibasic injection, solution, concentrate

amneal pharmaceuticals private limited - potassium phosphate, monobasic (unii: 4j9fj0hl51) (potassium cation - unii:295o53k152, phosphate ion - unii:nk08v8k8hr), potassium phosphate, dibasic (unii: ci71s98n1z) (potassium cation - unii:295o53k152, phosphate ion - unii:nk08v8k8hr) - potassium phosphates injection is indicated as a source of phosphorus: - in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. - for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated. potassium phosphates injection is contraindicated in patients with: - hyperkalemia [see warning and precautions (5.3)]. - hyperphosphatemia [see warning and precautions (5.4)]. - hypercalcemia or significant hypocalcemia [see warning and precautions (5.4)] . - severe renal impairment (egfr less than 30 ml/min/1.73 m2 ) or end stage renal disease [see warning and precautions (5.3)] . risk summary administration of the recommended dose of potassium phosphates injection is not expected to cause major birth defects, miscarriage or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with potassium phosphates injection. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. clinical considerations disease-associated maternal and/or embryo-fetal risk phosphorus is an essential mineral element. parenteral supplementation with potassium phosphates should be considered if a pregnant woman’s requirements cannot be fulfilled by oral or enteral intake. risk summary phosphorus and potassium are present in human milk. administration of the recommended dose of potassium phosphates injection is not expected to cause harm to a breastfed infant. there is no information on the effects of potassium phosphates on milk production. the development and health benefits of breastfeeding should be considered along with the mother’s clinical need for potassium phosphates injection and any potential adverse effects on the breastfed child from potassium phosphates injection or from underlying maternal condition. safety and effectiveness of potassium phosphates injection have been established in pediatric patients as a source of phosphorus: - in intravenous fluids to correct hypophosphatemia when oral or enteral replacement is not possible, insufficient, or contraindicated. - for parenteral nutrition when oral or enteral nutrition is not possible, insufficient or contraindicated. because of immature renal function, preterm infants receiving prolonged parenteral nutrition treatment with potassium phosphates injection may be at higher risk of aluminum toxicity [see warnings and precautions (5.6)] . in general, dose selection of potassium phosphates injection for an elderly patient should be cautious, starting at the low end of the dosing range because of the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy. it may be useful to monitor renal function during treatment [see use in specific populations (8.6)] . potassium and phosphorus are known to be substantially excreted by the kidney and the risk of adverse reactions to potassium phosphates injection may be greater in patients with impaired renal function [see warnings and precautions (5.3, 5.4, 5.5)] . potassium phosphates injection is contraindicated due to the risk of hyperkalemia in patients with severe renal impairment (egfr less than 30 ml/min/1.73 m2 ) or end stage renal disease [see contraindications (4)] . in patients with moderate renal impairment (egfr ≥ 30 ml/min/1.73 m2 to < 60 ml/min/1.73 m2 ), start at the low end of the dosage range and monitor serum potassium, phosphorus, calcium and magnesium concentrations [see dosage and administration (2.2, 2.4)].

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

phozguard 620 systemic fungicide

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

searles root rot systemic fungicide

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

grow-phos 600 systemic fungicide

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sprayphos 600 systemic fungicide

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade dominator 600 fungicide

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agri-fos 600 systemic fungicide